GeneDx Stock Quote WGS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

69.98

Bid

68.01

Ask

74.89

Volume

179

0.00 Day's Range 0.00

3.63 52 Week Range 98.87

Market Cap

1.922B

Previous Close

69.98

Open

Last Trade

71.45

Last Trade Time

04:17:24

Financial Volume

VWAP

Average Volume (3m)

642,298

Shares Outstanding

27,471,397

Dividend Yield

PE Ratio

-10.94

Earnings Per Share (EPS)

-6.4

Revenue

202.57M

Net Profit

-175.77M

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and... GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut. Show more

Sector

Blank Checks

Industry

Health Services

Website

www.genedx.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

GeneDx Holdings Corporation is listed in the Blank Checks sector of the NASDAQ with ticker WGS. The last closing price for GeneDx was $69.98. Over the last year, GeneDx shares have traded in a share price range of $ 3.63 to $ 98.87.

GeneDx currently has 27,471,397 shares outstanding. The market capitalization of GeneDx is $1.92 billion. GeneDx has a price to earnings ratio (PE ratio) of -10.94.

Overall Flow

Bullish

Net Premium

181k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced it will release financial results for the fourth quarter 2024 and the full year 2024...

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that, effective as of January 14, 2025, the compensation committee...

GeneDx Announces Preliminary 2024 Financial Results

Expects to exceed guidance with full year 2024 revenues1 of at least $299 million Expects fourth quarter 2024 revenues1 of at least $92 million Expects to exceed guidance with full year 2024...

GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a new way to provide genetic counseling and test-ordering services for patients and...

GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

Contributed nearly one quarter of all submissions to GeneMatcher and collaborated on more than 85 peer reviewed publications in 2024 GeneDx (Nasdaq: WGS), a leader in delivering improved health...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-6.02	-7.92105263158	76	82.49	68.33	566422	75.50113835	CS
4	-22.13	-24.0256215395	92.11	98.87	66.8076	870050	79.11013941	CS
12	-2.87	-3.93960192176	72.85	98.87	66	642298	77.99678149	CS
26	43.77	166.997329264	26.21	98.87	25.84	577266	65.41903968	CS
52	66.13	1717.66233766	3.85	98.87	3.63	494301	46.77276219	CS
156	59.057	540.666483567	10.923	98.87	1.16	936839	20.75065396	CS
260	59.057	540.666483567	10.923	98.87	1.16	936839	20.75065396	CS

WGS - Frequently Asked Questions (FAQ)

What is the current GeneDx share price?

The current share price of GeneDx is $ 69.98

How many GeneDx shares are in issue?

GeneDx has 27,471,397 shares in issue

What is the market cap of GeneDx?

The market capitalisation of GeneDx is USD 1.92B

What is the 1 year trading range for GeneDx share price?

GeneDx has traded in the range of $ 3.63 to $ 98.87 during the past year

What is the PE ratio of GeneDx?

The price to earnings ratio of GeneDx is -10.94

What is the cash to sales ratio of GeneDx?

The cash to sales ratio of GeneDx is 9.49

What is the reporting currency for GeneDx?

GeneDx reports financial results in USD

What is the latest annual turnover for GeneDx?

The latest annual turnover of GeneDx is USD 202.57M

What is the latest annual profit for GeneDx?

The latest annual profit of GeneDx is USD -175.77M

What is the registered address of GeneDx?

The registered address for GeneDx is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the GeneDx website address?

The website address for GeneDx is www.genedx.com

Which industry sector does GeneDx operate in?

GeneDx operates in the HEALTH SERVICES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EVAXEvaxion Biotech AS	$ 3.81 (58.75%)	4.61M
TNFATNF Pharmaceuticals Inc	$ 0.98 (34.62%)	100
PTIRGraniteShares 2X Long PLTR Daily ETF	$ 208.54 (34.27%)	35.24k
PLTUDirexion DAily PLTR Bull 2X Shares	$ 44.16 (33.86%)	52.96k
SUGPSU Group Holdings Ltd	$ 1.20 (21.24%)	1
UPCUniverse Pharmaceuticals Inc	$ 0.3047 (-27.00%)	17.73k
UOKAMDJM Ltd	$ 0.1759 (-26.09%)	401.08k
TENXTenax Therapeutics Inc	$ 4.48 (-24.71%)	98
BCTXBriaCell Therapeutics Corporation	$ 3.82 (-24.21%)	7.05k
EJHE Home Household Service Holdings Ltd	$ 0.775 (-24.02%)	29.74k
IVVDInvivyd Inc	$ 1.27 (19.81%)	4.72M
EVAXEvaxion Biotech AS	$ 3.81 (58.75%)	4.61M
BHATBlue Hat Interactive Entertainment Technology	$ 0.0404 (-12.55%)	1.79M
CYNCYNGN Inc	$ 0.1057 (-9.58%)	1.4M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.1732 (-11.13%)	1.36M